4.7 Article

microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma

期刊

JOURNAL OF HEMATOLOGY & ONCOLOGY
卷 8, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s13045-015-0150-4

关键词

microRNA-26a; Hepatocellular carcinoma; M-CSF; Macrophages

资金

  1. National Natural Science Foundation of China [81472224, 81372655]
  2. National Science and Technology Project for Infectious Diseases [2012ZX10002-017, 2013ZX10002007, 2012ZX10002012-004]
  3. Shanghai Natural Science Fund for Youth Scholars [12ZR1442300]

向作者/读者索取更多资源

Background: microRNAs (miRNAs) have been reported to modulate macrophage colony-stimulating factor (M-CSF) and macrophages. The aim of this study was to find whether miR-26a can suppress M-CSF expression and the recruitment of macrophages. Methods: Hepatocellular carcinoma (HCC) cell lines with decreased or increased expression of miR-26a were established in a previous study. M-CSF expression by tumor cells was measured by enzyme-linked immunosorbent assay, and cell migration assays were used to explore the effect of HCC cell lines on macrophage recruitment in vitro. Real-time PCR measured a panel of mRNAs expressed by macrophages. Xenograft models were used to observe tumor growth. Immunohistochemistry was conducted to study the relation between miR-26a expression and M-CSF expression and macrophage recruitment in patients with HCC. Results: Ectopic expression of miR-26a reduced expression of M-CSF. The conditioned medium (CM) from HepG2 cells that overexpressed miR-26a reduced the migration ability of THP-1 cells stimulated by phorbol myristate acetate (PMA) increased expression of interleukin (IL)-12b or IL-23 mRNA and decreased expression of chemokine (C-C motif) ligand (CCL) 22, CCL17, and IL-10 mRNA, in comparison to the medium from the parental HepG2 cells. These effects could be interrupted by the PI3K/Akt pathway inhibitor LY294002. Ectopic expression of miR-26a in HCC cells suppressed tumor growth, M-CSF expression, and infiltration of macrophages in tumors. Similar results were also found when using HCCLM3 cells. Furthermore, the expression of miR-26a was inversely correlated with M-CSF expression and macrophage infiltration in tumor tissues from patients with HCC. Conclusions: miR-26a expression reduced M-CSF expression and recruitment of macrophages in HCC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma A Single Center Study of 45 Patients

Zheng Wang, Yuanfei Peng, Jingwu Hu, Xiaoying Wang, Huichuan Sun, Jian Sun, Yinghong Shi, Yongsheng Xiao, Zhenbing Ding, Xinrong Yang, Min Tang, Zhaoyou Tang, Jiping Wang, Wan Y. Lau, Jia Fan, Jian Zhou

ANNALS OF SURGERY (2020)

Article Surgery

A prospective study of the effect of terlipressin on portal vein pressure and clinical outcomes after hepatectomy: A pilot study

Xiao-Long Li, Xiao-Dong Zhu, Nan Xiao, Xue-Feng Liu, Bin Xu, Guo-Ming Shi, Cheng Huang, Ying-Hao Shen, Jia-Bin Cai, Jian Zhou, Jia Fan, Hui-Chuan Sun

SURGERY (2020)

Article Biochemistry & Molecular Biology

Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma

Man-Qing Cao, A-Bin You, Wei Cui, Su Zhang, Zhi-Gui Guo, Lu Chen, Xiao-Dong Zhu, Wei Zhang, Xiao-Lin Zhu, Hua Guo, Da-Jun Deng, Hui-Chuan Sun, Ti Zhang

FASEB JOURNAL (2020)

Article Cell Biology

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma

Kang-Shuai Li, Xiao-Dong Zhu, Hong-Da Liu, Shi-Zhe Zhang, Xiao-Long Li, Nan Xiao, Xue-Feng Liu, Bin Xu, Ming Lei, Yuan-Yuan Zhang, Wen-Kai Shi, Man-Qing Cao, Yun-Fei Xu, Zhao-You Tang, Hui-Chuan Sun

CELL DEATH & DISEASE (2020)

Article Biotechnology & Applied Microbiology

Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis

Jin-Wu Hu, Guang-Yu Ding, Pei-Yao Fu, Wei-Guo Tang, Qi-Man Sun, Xiao-Dong Zhu, Ying-Hao Shen, Jian Zhou, Jia Fan, Hui-Chuan Sun, Cheng Huang

BIOMED RESEARCH INTERNATIONAL (2020)

Article Oncology

Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma

Guang-Yu Ding, Xiao-Dong Zhu, Yuan Ji, Guo-Ming Shi, Ying-Hao Shen, Jian Zhou, Jia Fan, Hui-Chuan Sun, Cheng Huang

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Article Oncology

Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis

Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Dong Wu, Yuan Ji, Ning-Ling Ge, Ling-Li Chen, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun

Summary: The study found that in patients with advanced hepatocellular carcinoma, first-line lenvatinib plus anti-PD-1 antibodies resulted in higher organ-specific response rates for macrovascular tumor thrombi (MVTT), potentially allowing for surgical resection in a proportion of patients.

BIOMARKER RESEARCH (2021)

Article Oncology

PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma

Shi-Zhe Zhang, Xiao-Dong Zhu, Long-Hai Feng, Xiao-Long Li, Xue-Feng Liu, Hui-Chuan Sun, Zhao-You Tang

Summary: The study revealed that high expression of PCSK9 in hepatocellular carcinoma (HCC) is associated with microvascular invasion and large tumor size, leading to poor overall survival and disease-free survival in patients. Experimental findings demonstrated that PCSK9 promotes HCC growth by inhibiting cell apoptosis, with FASN-mediated anti-apoptosis playing a significant role in this process.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

Article Oncology

Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trial

Hui-Chuan Sun, Xiao-Dong Zhu, Jian Zhou, Qiang Gao, Ying-Hong Shi, Zhen-Bing Ding, Cheng Huang, Shuang-Jian Qiu, Ning Ren, Guo-Ming Shi, Jian Sun, Qing-Hai Ye, Xiao-Wu Huang, Xin-Rong Yang, Jia Fan

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

Targeting angiogenesis for liver cancer: Past, present, and future

Xiao-Dong Zhu, Zhao-You Tang, Hui-Chuan Sun

GENES & DISEASES (2020)

Review Biochemistry & Molecular Biology

Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects

Xiao-Dong Zhu, Kang-Shuai Li, Hui-Chuan Sun

GENES & DISEASES (2020)

暂无数据